Unveiling therapeutic avenues targeting xCT in head and neck cancer

被引：0
|
作者：
Lee, Jaewang [1 ]
Roh, Jong-Lyel [1 ,2 ]
机构：
[1] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam 13496, Gyeonggi Do, South Korea
[2] CHA Univ, Gen Grad Sch, Dept Biomed Sci, Pochon, South Korea
来源：
CELLULAR ONCOLOGY | 2024年 / 47卷 / 06期
基金：
新加坡国家研究基金会;
关键词：
xCT; Ferroptosis; Head and neck cancer; Resistance; Therapy; REGULATES FERROPTOSIS; CISPLATIN RESISTANCE; TUMOR PROGRESSION; CIRCULAR RNAS; CELL-DEATH; METABOLISM; PATHWAY; NRF2; TRANSPORTER; EXPRESSION;
D O I：
10.1007/s13402-024-00997-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Head and neck cancer (HNC) remains a major global health burden, prompting the need for innovative therapeutic strategies. This review examines the role of the cystine/glutamate antiporter (xCT) in HNC, specifically focusing on how xCT contributes to cancer progression through mechanisms such as redox imbalance, ferroptosis, and treatment resistance. The central questions addressed include how xCT dysregulation affects tumor biology and the potential for targeting xCT to enhance treatment outcomes. We explore recent developments in xCT-targeted current and emerging therapies, including xCT inhibitors and novel treatment modalities, and their role in addressing therapeutic challenges. This review aims to provide a comprehensive analysis of xCT as a therapeutic target and to outline future directions for research and clinical application.
引用
收藏
页码：2019 / 2030
页数：12
相关论文
共 50 条
  • [1] Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer
    Wang, Zechen
    Anderson, Karen S.
    CANCER JOURNAL, 2022, 28 (05): : 354 - 362
  • [2] Unlocking the Reverse Targeting Mechanisms of Cannabidiol: Unveiling New Therapeutic Avenues
    Zeng, Wen
    Wang, Yifei
    Gao, Rui
    Wen, Hongliang
    Yu, Mingjia
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 14574 - 14585
  • [3] Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials
    Beckham, Thomas H.
    Elojeimy, Saeed
    Cheng, Joseph C.
    Turner, Lorianne S.
    Hoffman, Stanley R.
    Norris, James S.
    Liu, Xiang
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (05) : 529 - 539
  • [4] Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit
    Johnson, Daniel E.
    CHINESE JOURNAL OF CANCER, 2012, 31 (07) : 319 - 326
  • [5] Unveiling novel therapeutic avenues: Targeting the cyclin D/CDK4 axis for enhanced cancer treatment
    Lokhande, Kiran Bharat
    Shrivastava, Ashish
    Singh, Ashutosh
    MEDICAL HYPOTHESES, 2024, 185
  • [6] Advancing head and neck cancer management: Unveiling the diagnostic and therapeutic potentials of molecular profiling
    Baral, Binav
    Suleiman, Riham
    Fazer-Posorske, Casey A.
    Ma, Daniel J.
    Mcgarrah, Patrick W.
    Thome, Stephan D.
    Molina, Julian R.
    Price, Katharine A.
    Halfdanarson, Thorvardur R.
    Fuentes, Harry E.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (10): : E84 - E90
  • [7] Cholesterol-ferroptosis nexus: Unveiling novel cancer therapeutic avenues
    Lee, Jaewang
    Roh, Jong-Lyel
    CANCER LETTERS, 2024, 597
  • [8] Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
    Mudra, Sarah E.
    Sadhukhan, Pritam
    Ugurlu, M. Talha
    Alam, Shorna
    Hoque, Mohammad O.
    CANCERS, 2021, 13 (20)
  • [9] Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer
    Bos, Tasia
    Ratti, J. Alex
    Harada, Hisashi
    FRONTIERS IN ORAL HEALTH, 2021, 2
  • [10] Targeting Head and Neck Cancer by Vaccination
    Wang, Chuan
    Dickie, James
    Sutavani, Ruhcha V.
    Pointer, Catherine
    Thomas, Gareth J.
    Savelyeva, Natalia
    FRONTIERS IN IMMUNOLOGY, 2018, 9
12345